Literature DB >> 23209610

Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.

Wenjia Meng1, Chengqi Zhang, Qian Zhang, Xinhong Song, Haiyan Lin, Dongzhi Zhang, Yongyuan Zhang, Zhenxin Zhu, Shuo Wu, Yanxun Liu, Fang Tang, Xiaowei Yang, Fuzhong Xue.   

Abstract

BACKGROUND: Although cross-sectional studies have shown that leukocyte is linked with metabolic syndrome (MetS), few longitudinal or cohort studies have been used to confirm this relationship. We therefore conducted a large-scale health check-up longitudinal cohort in urban Chinese population from middle to upper socioeconomic strata to investigate and prove the association between the total leukocyte/its subtypes and MetS/its components (obesity, hyperglycemia, dyslipidemia, and hypertension).
METHODS: A longitudinal cohort study was established in 2005 on individuals who were middle-to-upper class urban Chinese. Data used in this investigation was based on 6,513 participants who had at least three routine health check-ups over a period of six-year follow-up. Data analysis was conducted through generalized estimating equation (GEE) model.
RESULTS: A total of 255 cases of MetS occurred over the six-year follow-up, leading to a total incidence density of 11.45 per 1,000 person-years (255/22279 person-years). The total leukocyte was markedly associated with MetS (RR = 2.66, 95%CI = 1.81-3.90], p<0.0001) and a dose-response existed. Similar trends can be found in monocytes, lymphocytes, and neutrophils compared with the total leukocyte. The total leukocyte, neutrophil, monocyte and eosinophil levels were strong and independent risk factors to obesity, total leukocyte and neutrophil to dyslipidemia and hyperglycemia, while neither total leukocyte nor its subtypes to hypertension.
CONCLUSION: Total leukocyte/its subtype were associated with MetS/its components (obesity, dyslipidemia and hyperglycemia), they might provide convenient and useful markers for further risk appraisal of MetS, and be the earlier biomarkers for predicting cardiovascular disease than the components of MetS.

Entities:  

Mesh:

Year:  2012        PMID: 23209610      PMCID: PMC3507923          DOI: 10.1371/journal.pone.0049875

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Metabolic syndrome (MetS) refers to a constellation of metabolic and cardiovascular disease (CVD) risk factors, characterized by obesity, hyperglycemia, dyslipidemia, hypertension and insulin resistance, proinflammatory state, and prothrombotic state [1], [2]. It is rapidly increasing in prevalence and poses as a major challenge to public health worldwide [3]–[7]. The fact that MetS is accompanied by a low-grade inflammation suggests inflammation may play an important role in the etiology [8], [9]. Various cross-sectional studies indicated that serum C-reactive protein (CRP) levels were higher among individuals with increased MetS risk factors [10]–[14], and a large cohort study of healthy American women over an eight-year follow-up suggested that CRP had clinically important prognostic information to MetS [15]. Although high sensitivity CRP (hs-CRP) was superior to leukocyte count as an inflammatory component of MetS in Japanese [16], the latter provided a higher diagnostic accuracy for MetS in a study of Koreans, suggesting that leukocyte may be a risk and prognostic factor for the syndrome when hs-CRP is not available. In addition to cross-sectional studies with suggestions that elevated leukocyte counts were a surrogate marker for MetS [17]–[23], some attempts were also made with cohort or longitudinal data indicating that leukocyte was a potential causal factor of MetS [24]–[26]. Despite awareness of the limitation with cross-sectional studies [18]–[23], the longitudinal studies just mentioned [25], only utilized the baseline leukocyte count which is known to fluctuate during the lifespan of most people. Furthermore, few studies have assessed the relationship between subtype(s) of leukocyte and MetS/its components (obesity, hyperglycemia, dyslipidemia, and hypertension). We, therefore, conducted a large-scale health check-up based longitudinal cohort study in urban Han Chinese population from middle to upper socioeconomic strata, and the generalized estimating equation (GEE) model was used to detect the association between the total leukocyte/its subtypes and MetS/its single components. The longitudinal cohort study allowed us to use repeated observations of the same set of variables during the follow-up, and the GEE model can not only adjust for the inherent correlations between the observations, but also provide robust standard errors for regression coefficients when the independence assumption is violated [27]. Since the total l leukocyte/its subtypes are simple, readily available and inexpensive measures, findings from such a study may provide convenient and useful markers for further risk appraisal of MetS. P<0.05. The abbreviations of the variables: GGT = gamma-glutamyltranspeptidase; ALB =  serum albumin; GLO = serum globulins; BUN = blood urea nitrogen; S-Cr = serum creatinine; TC = Total cholesterol; Hb = Hemoglobin; HCT = Hematokrit; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; RDW =  Red blood cell distribution width; PDW = Platelet distribution width; MPV =  mean platelet volume; PCT  = Thrombocytocrit; Diet: 0: Vegetarian, 1: normal, 2: meat-based 3: sea food (the major kinds of food used to have); Drinking: 0: never, 1: seldom, 2: often, wine,3: often beer, 4: often, Chinese spirits,5: often, mixed all kinds; Smoking: 0: never,1: seldom,2: quit,3:1–4/d, 4: 5–15/d, 5: >15/d; Quality of sleep 0: excellent, 1: well, 2: fair 3: poor, 4: very poor (evaluated by themselves); Physical activity 0: never, 1: seldom (1–2 times a week), 2: often or everyday (more than 3 times a week).

Materials and Methods

Study samples

A large scale longitudinal cohort study was set up in 2005 on middle-to-upper class urban Han Chinese who attended routine health checks at Centers for Health Management of Shandong Provincial Qianfoshan Hospital and of Shandong Provincial Hospital. A sub-cohort was selected from those free of MetS nor its components (obesity, dyslipidemia, hyperglycemia, and hypertension) at baseline. A total of 6,513 participants with at least three health checks in the six-year follow-up were included in our study. All individuals in the sub-cohort underwent a general health questionnaire, anthropometric, and laboratory test. The general health questionnaire covered smoking, alcohol intake, diet, sleeping quality and physical activity. The anthropometric tests included height, weight, and blood pressure, with both height and weight measured with light clothing without shoes. Body mass index (BMI) was calculated as weight/height2 (kg/m2) as an evidence of obesity. Blood pressure was measured on the right arm from a sitting position following a 5-min rest. Laboratory tests included total leukocyte/its subtypes, glucose, total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides (TG), uric acid(UA), gamma-glutamyl transpeptidase (GGT), serum albumin(ALB), serum globulins(GLO), blood urea nitrogen (BUN), serum creatinine (S-Cr), hemoglobin (Hb), hematokrit (HCT), mean corpuscular volume(MCV), mean corpuscular hemoglobin (MCH), red blood cell distribution width (RDW), platelet distribution width (PDW), mean platelet volume (MPV) and thrombocytocrit (PCT). This study was approved by the Ethics Committee of School of Public Health, Shandong University, and all participants gave informed written consent.

Definition of Metabolic Syndrome

According to the criteria given by the Chinese Medical Association Diabetes Branch (CDS) designed for Chinese [28], MetS was defined as presence of three or more of the following four risk factors: 1) obesity or overweight, BMI≥25 0kg/m2; 2) hypertension, systolic/diastolic blood pressure ≥140/90 mmHg or previous diagnosis; 3) dyslipidemia, defined as fasting TG≥1.7 mmol/L(110 mg/dl), or fasting high-density(HDL)<0.9 mmol/L(35 mg/dl); 4) hyperglycemia, fasting blood-glucose (FPG)≥6.1 mmol/L(110 mg/dl) or 2 h Post-meal glucose (PG)≥7.8 mmol/L(140 mg/dl), or previous diagnosis.

Statistical Analysis

Missing Data Imputation

To account for missing values, multiple imputation was performed. Since imputation method of choice depended on the pattern of missingness and the type of the imputed variables, without loss of generality the Markov chain Monte Carlo (MCMC) method was chosen according to MI Procedure of SAS 9.2[29]. After imputation, all variables had less than 10% missing observations, in particular, less than 2% for the total leukocyte and its subtypes, and 1% for other variables except diet, drinking, smoking, quality of sleep and physical activity.

Data analysis

Summary statistics were obtained for variables of interest at both baseline and follow-up. Simple GEE model was first used to select factors associated with MetS, and multiple GEE model was further adopted to detect the association between leukocyte/its subtypes counts and MetS/its components [30]–[33]. Variables which were significant at the significant level of 0.05 (α) in the simple GEE analysis entered the multiple GEE model to adjust the potential confounding. The GEE models used ‘Logit’ as the link function, adjusted for baseline age, and those P<0.05 were considered significant. All statistical analysis was performed by SAS 9.2.

Results

Shown in Table 1 are the characteristics of the total leukocyte/its subtype, together with potential confounding factors at baseline and each follow-up year. This indicated that they were generally higher than baseline (P<0.05), though some did not reach statistical significance. A total of 255 cases of MetS occurred over the six-year follow-up, leading to a total incidence density of 11.45 per 1,000 person-years (255/22279 person-years), with 1.7, 9, 12.6,18.2 and 19.6 per 1,000 person-years of follow-up in the 1st, 2nd, 3rd, 4th and 5th year, respectively.
Table 1

Distribution of leukocyte/its subtype, and other potential confounding factors.

baseline1-yearfollow-up2-year follow-up3-year follow-up4-year follow-up5-year follow-up
variablesNMean±StdNMean±StdNMean±StdNMean±StdNMean±StdNMean±Std
Leukocyte14806.26±1.4239886.27±1.4852606.26±1.5454656.26±1.47* 56176.26±1.5039206.28±1.50*
lymphocyte14802.09±0.5639881.87±0.50* 52602.04±4.7654651.93±0.5756172.00±0.6439202.21±0.59*
monocyte14800.37±0.1139880.35±0.1152600.33±0.11* 54650.33±0.12* 56170.34±0.1339200.36±0.12
neutrophil14803.64±1.1439883.79±1.16* 52603.70±1.1654653.63±1.1456173.66±1.1339203.64±1.15
eosnophil14800.15±0.1539880.13±0.1352600.14±0.1254650.13±0.1256170.14±0.1339200.14±0.12
basophil14800.02±0.0239880.02±0.0352600.02±0.0254650.02±0.0156170.01±0.0139200.03±0.02
age157138.86±11.73406439.28±11.78540740.47±11.98561240.78±11.72564241.95±11.73392543.02±11.93
GGT148017.67±17.4398818.30±16.16526020.27±19.66* 546519.08±16.59* 561720.63±20.19* 392021.57±19.6*
ALB148045.91±1.91398847.36±2.15* 526045.25±2.74546545.81±2.88561744.88±2.62392045.12±2.37
GLO148027.81±3.58398826.22±3.88526027.30±3.90546527.73±3.85561728.82±3.45392031.51±3.37*
BUN14804.86±1.239884.82±1.1952604.65±1.1754654.70±1.1756174.73±1.239204.82±1.15
S-Cr148079.59±13.51398876.36±14.2526077.72±13.56546578.28±14.17561778.76±14.42392075.49±12.49*
TC14804.74±0.8639884.80±0.8652604.85±0.9054654.84±0.9356175.00±0.9539205.22±0.96*
Hb1480142.08±15.243988142.77±14.745260143.67±15.135465141.46±14.995617142.22±15.353920141.97±16.51
HCT148042.9±4.03398843.19±3.86526042.45±3.86546542.2±3.84561742.02±4.00392041.64±3.88
MCV148090.64±4.88398890.36±4.7526030.32±2.08546589.64±4.72561789.71±4.92392088.53±4.90*
MCH148030.00±2.00398829.85±1.91526012.77±0.98546530.03±2.07561730.36±2.29392030.15±2.16
RDW148012.74±1.07398812.83±0.9852606.04±1.47546512.78±0.96561712.77±1.03392012.82±1.03*
PDW148012.31±1.70398812.38±1.75526012.31±1.71546512.27±1.68561712.17±1.66392012.46±1.63*
MPV148010.46±0.84398810.45±0.99526010.43±0.81546510.44±0.80561710.37±0.80392010.47±0.80
PCT14800.23±0.1039880.25±0.152600.26±0.3254650.25±0.0556170.25±0.0539200.25±0.32

P<0.05.

The abbreviations of the variables: GGT = gamma-glutamyltranspeptidase; ALB =  serum albumin; GLO = serum globulins; BUN = blood urea nitrogen; S-Cr = serum creatinine; TC = Total cholesterol; Hb = Hemoglobin; HCT = Hematokrit; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; RDW =  Red blood cell distribution width; PDW = Platelet distribution width; MPV =  mean platelet volume;

PCT  = Thrombocytocrit; Diet: 0: Vegetarian, 1: normal, 2: meat-based 3: sea food (the major kinds of food used to have); Drinking: 0: never, 1: seldom, 2: often, wine,3: often beer, 4: often, Chinese spirits,5: often, mixed all kinds; Smoking: 0: never,1: seldom,2: quit,3:1–4/d, 4: 5–15/d, 5: >15/d; Quality of sleep 0: excellent, 1: well, 2: fair 3: poor, 4: very poor (evaluated by themselves); Physical activity 0: never, 1: seldom (1–2 times a week), 2: often or everyday (more than 3 times a week).

Before GEE analysis, the total leukocyte/its subtype were orderly discretized by P 25, P 50 P 75 quartiles (see Table S1). Shown in Table S2 to S6 were the results of the simple GEE analysis. This suggesting that a) Age, gender, Leukocyte, Lymphocyte, Monocyte, Neutrophil, GGT, ALB, GLO, BUN, TC, Hb, HCT, MCH, diet, drinking and smoking were associated with MetS(see Table S2); b)All variables except basophil, PDW, MPV, PCT, quality of sleep and physical activity with obesity (see Table S3); c) All variables except basophil, PDW and PCT with dyslipidemia (see Table S4); d) All variables except eosnophils, basophil, PDW, MPV, PCT, drinking, quality of sleep and exercise with hyperglycemia (see Table S5); e) All variables except leukocyte, lymphocyte, monocyte, neutrophil, eosnophils, GGT, MCH, diet, drinking, smoking and quality of sleep with hypertension (see Table S6). Shown in Table 2 were the association between the total leukocyte and MetS after adjusting the potential confounders in the multiple GEE analysis, such that it was associated with MetS at the top quartile (RR = 2.66, 95%CI = 1.81–3.90); p<0.0001), the third quartile (RR = 1.60, 95%CI = 1.06–2.38); p = 0.0243) levels using the Q1 as reference level. Although not significant at Q2, a trend of increase of RR was observed from Q2 to Q4. Shown in Table 3 was the association between the leukocyte subtypes and MetS after adjusting the potential confounders in the multiple GEE analysis, suggesting that similar trends can be found in monocytes, lymphocytes, and neutrophils compared with the total leukocyte, though some levels did not reach statistical significance.
Table 2

Results after adjusting for potential confounding factors.

QuartilesEstimateZPr>|Z|RRlower 95% Confidence Limitsupper 95% Confidence Limits
leukocyte
Q40.97654.99<0.00012.65511.80893.8970
Q30.46422.250.02431.59071.06222.3824
Q20.31661.490.13621.37250.9052.0815
Q1refrefrefref11
age0.02093.300.00101.02111.00851.0339
gender0.03760.150.87761.03830.64381.6743
time0.21645.58<0.00011.24161.15071.3398
GGT0.01026.43<0.00011.01031.00711.0134
TP−0.0028−0.040.96970.99720.86241.1530
ALB−0.0168−0.180.85340.98330.82321.1747
GLO−0.0396−0.430.66460.96120.80341.1498
A/G−1.2350−1.170.24300.29080.03662.3120
BUN0.17734.10<0.00011.1941.09701.2995
TC0.37345.54<0.00011.45271.27281.6580
HB−0.0244−0.210.83200.97590.77931.2223
HCT0.16720.430.66481.1820.55472.5186
MCV−0.1007−6.00<0.00010.90420.87490.9344
diet0.03670.540.58921.03740.90801.1852
drinking0.05661.260.20871.05820.96881.1559
smoking0.01700.440.65841.01710.94331.0969
Table 3

Results after adjusting for other potential confounding factors.

QuartilesEstimateZPr>|Z|RRlower 95% Confidence Limitsupper 95% Confidence Limits
lymphcyte
Q40.50872.670.00761.66311.14472.4165
Q3−0.1341−0.650.51420.87450.58451.3084
Q2−0.0655−0.330.74280.93660.63321.3851
Q1refrefrefref11
monocyte
Q40.01150.050.95961.01160.64851.5779
Q30.20660.970.32981.22950.81161.8625
Q20.11200.540.58751.11850.74631.6762
Q1refrefrefref11
neutrophils
Q40.74163.840.00012.09931.43733.0658
Q30.17890.910.36441.19590.81251.7602
Q20.09750.50.61851.10240.75111.6179
Q1refrefrefref11
age0.02213.440.00061.02231.00951.0352
gender0.03010.120.90251.03060.63721.6668
time0.20795.21<0.00101.23111.13841.3314
GGT0.01056.33<0.00101.01061.00731.0139
ALB−0.0195−0.210.83750.98070.81401.1815
GLO−0.0464−0.500.62000.95470.79461.1469
BUN0.17884.12<0.0011.19581.09821.3020
TC0.37065.45<0.0011.44861.26791.6550
Hb−0.0273−0.240.81330.97310.77551.2208
HCT0.17330.450.65591.18920.55492.5482
MCV−0.1012−5.91<0.0010.90380.87390.9345
diet0.03850.570.57061.03930.90971.1873
drinking0.06161.340.17901.06350.97211.1636
smoking0.01390.350.72671.01400.93821.0958
The association of the total leukocyte/its subtypes with single MetS component (obesity, diabetes, hypertension and dyslipidemia) were further explored and shown in Tables S7, S8, S9, S10, S11, S12, S13. The total leukocyte, neutrophil, monocyte and eosinophil levels were strong and independent risk factors to obesity and an obvious increased trend of RR are revealed from Q2 to Q4 after adjusting the potential confounding factors (see Table S7 and Table S8). For hypertension, neither total leukocyte nor its subtypes were statistically significant (see Table S9). Nevertheless, the total leukocyte and neutrophil were strong and independent risk factors to dyslipidemia(see Table S10 and Table S11). Finally, for hyperglycemia, the total leukocyte and neutrophil were significant, though not at the second quartile (see Table S12 and Table S13).

Discussion

This work mainly focus on detecting the association between the total leukocyte/ its subtypes and MetS/its components using the routine health-check based longitudinal cohort of urban Han Chinese population from middle to upper socioeconomic strata. The total incidence density was 11.45 per 1,000 person-years, with 1.7, 9, 12.6, 18.2 and 19.6 per 1,000 person-years of follow-up in the 1st, 2nd, 3rd, 4th and 5th year, respectively. Similar trend was reported in Japanese employee population [26]. We found that the total leukocyte was strongly associated with MetS and a dose-response existed (see Table 2). Furthermore, similar trends can be found in monocytes, lymphocytes, and neutrophils compared with the total leukocyte, though some levels did not reach statistical significance (see Table 3). In addition, similar findings were also reported by different study in different population, including a health check-up cohort in South China [25], Japanese employee population [26], and black-white population (preadolescents, adolescents, and adults)[16], These consistent conclusions indicated that the total leukocyte/its subtype may provide convenient and useful markers for further risk appraisal of MetS. The associations of the total leukocyte/its subtype with single MetS component (obesity, diabetes, hypertension and dyslipidemia) were also identified in this paper. The total leukocyte, neutrophil, monocyte and eosinophil levels were strong and independent risk factors to obesity (see Table S7 and Table S8), total leukocyte and neutrophil to dyslipidemia(see Table S10 and Table S11)and hyperglycemia (see Table S12 and Table S13), while neither total leukocyte nor its subtypes to hypertension (see Table S9). Our finding confirmed the conclusions drawn from previous cross-section studies [18], [20], [34], [34,35,35]. Therefore, our results highlighted the association between the total leukocyte/its subtype and a variety of features of the MetS, indicating that they may be the earlier biomarkers for predicting cardiovascular disease than the components of MetS. Although the mechanism of the relationship between leukocyte and metabolic syndrome remained unclear, several explanations have been offered: a) Insulin resistance played an important role in metabolic disturbances [36], [37], leading to higher gathering of inflammatory markers, including the total leukocyte and other inflammatory factors, such as CRP, IL-6, tumor necrosis factor-α (TNF-α), As a result, statistical association between the total leukocyte and MetS in population can be detected [38], [39]. b) Both obesity and dyslipidemia were the major precursors for development of MetS, and perivascular white adipose tissue can release proinflammatory cytokines [40], such as IL-8, leading to elevated leukocyte, especially the monocytes and granulocytes. In addition, TNF-α is shown to be constitutively expressed by adipose tissue, and this proinflammatory cytokines leads to elevated leukocyte [41]–[43]. Therefore, the total leukocyte/its subtype were associated with MetS. c) Hypertension, hyperlipidemia or hyperglycemia were the major precursors of MetS which can damage vascular endothelial. Furthermore, vascular endothelial cells can produce intracellular adhesion molecule-1, which caused the leukocyte to adhere to the vascular wall [18], [44], resulting production of new cytokines and chemokines, then cytokines were potential inducers of leukocyte differentiation [45]. In return, activated differentiated leukocyte can produce more cytokines [46]–[48]. Neutrophils can aggregate and release damaging substances, such as free radicals and proteolytic enzymes. Free radicals can lead to dysfunction of vascular endothelial cells, and a vicious circle was built. Thus the statistical association between leukocyte (especially neutrophils) and MetS was discovered. A limitation of this study lie in the fact that use of routine health check-up population for middle-to-upper class urban Han Chinese can be subject to selection bias. Further investigation using general population is preferable. Due to the disadvantage of our routine health check-up database, we were unable to access the medical history of the participants. Owing to the absence of waist circumference measurement, the diagnostic criteria of MetS just based China Diabetes Federation, rather than international Standard criteria. In conclusion, the total leukocyte/its subtype may provide convenient and useful markers for further risk appraisal of MetS, and they might be the earlier biomarkers for predicting cardiovascular disease than the components of MetS. The quartiles of the total leukocyte/its subtypes. (DOCX) Click here for additional data file. The associated variables with MetS selected by the simple GEE model. (DOCX) Click here for additional data file. The associated variables with obesity selected by the simple GEE model. (DOC) Click here for additional data file. The associated variables with dyslipidemia selected by the simple GEE model. (DOC) Click here for additional data file. The associated variables with hyperglycemia selected by the simple GEE model. (DOC) Click here for additional data file. The associated variables with hypertension selected by the simple GEE model. (DOC) Click here for additional data file. Multiple GEE analysis of leukocyte and obesity after adjusting other potential confounding factors. (DOC) Click here for additional data file. Multiple GEE analysis of leukocyte subtypes and obesity after adjusting other potential confounding factors. (DOC) Click here for additional data file. Multiple GEE analysis of basophil and hypertension after adjusting other potential confounding factors. (DOC) Click here for additional data file. Multiple GEE analysis of leukocyte and dyslipidemia after adjusting other potential confounding factors. (DOCX) Click here for additional data file. Multiple GEE analysis of leukocyte subtypes and dyslipidemia after adjusting other potential confounding factors. (DOC) Click here for additional data file. Multiple GEE analysis of leukocyte and hyperglycemia after adjusting potential confounding factors. (DOC) Click here for additional data file. Multiple GEE analysis of leukocyte subtypes and hyperglycemia after adjusting other potential confounding factors. (DOCX) Click here for additional data file.
  46 in total

1.  White blood cell count and clustered features of metabolic syndrome in Japanese male office workers.

Authors:  N Nakanishi; K Suzuki; K Tatara
Journal:  Occup Med (Lond)       Date:  2002-06       Impact factor: 1.611

Review 2.  Epidemiology of the metabolic syndrome in the USA.

Authors:  Arthur J McCullough
Journal:  J Dig Dis       Date:  2011-10       Impact factor: 2.325

Review 3.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 4.  Insulin resistance and atherosclerosis.

Authors:  Babak Razani; Manu V Chakravarthy; Clay F Semenkovich
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

5.  Metabolic syndrome in Poland - the PONS Study.

Authors:  Imre Janszky; Lars Vatten; Pål Romundstad; Lars Erik Laugsand; Johan Håkon Bjørngård; Marta Mańczuk; Witold A Zatoński
Journal:  Ann Agric Environ Med       Date:  2011       Impact factor: 1.447

6.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

Review 7.  Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness.

Authors:  J M Fernández-Real; W Ricart
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

8.  Insulin resistance, inflammation, and serum fatty acid composition.

Authors:  José-Manuel Fernández-Real; Montserrat Broch; Joan Vendrell; Wifredo Ricart
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

9.  C-reactive protein and the risk of developing hypertension.

Authors:  Howard D Sesso; Julie E Buring; Nader Rifai; Gavin J Blake; J Michael Gaziano; Paul M Ridker
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

10.  Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study.

Authors:  Giovanni Zuliani; Stefano Volpato; Matteo Galvani; Alessandro Blè; Stefania Bandinelli; Anna Maria Corsi; Fulvio Lauretani; Marcello Maggio; Jack M Guralnik; Renato Fellin; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2008-08-12       Impact factor: 5.162

View more
  12 in total

1.  Effect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patients.

Authors:  Meltem Akcaboy; Serdar Kula; Tayfun Göktas; Bijen Nazlıel; Semiha Terlemez; Nurullah Celik; Bülent Celik; Necla Buyan
Journal:  Pediatr Nephrol       Date:  2015-10-19       Impact factor: 3.714

2.  Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study.

Authors:  Carlos Lorenzo; Anthony J Hanley; Steven M Haffner
Journal:  Diabetologia       Date:  2013-10-19       Impact factor: 10.122

3.  Identification of cardiovascular risk components in urban Chinese with metabolic syndrome and application to coronary heart disease prediction: a longitudinal study.

Authors:  Zhenxin Zhu; Yanxun Liu; Chengqi Zhang; Zhongshang Yuan; Qian Zhang; Fang Tang; Haiyan Lin; Yongyuan Zhang; Longjian Liu; Fuzhong Xue
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

4.  Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people.

Authors:  Hua Jiang; Wen-Hua Yan; Chan-Juan Li; An-Ping Wang; Jing-Tao Dou; Yi-Ming Mu
Journal:  Int J Environ Res Public Health       Date:  2014-05-20       Impact factor: 3.390

5.  A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population.

Authors:  Wenchao Zhang; Qicai Chen; Zhongshang Yuan; Jing Liu; Zhaohui Du; Fang Tang; Hongying Jia; Fuzhong Xue; Chengqi Zhang
Journal:  BMC Public Health       Date:  2015-01-31       Impact factor: 3.295

6.  Eosinophil Count Is a Common Factor for Complex Metabolic and Pulmonary Traits and Diseases: The LifeLines Cohort Study.

Authors:  Marzyeh Amini; Dinara Bashirova; Bram P Prins; Eva Corpeleijn; Marcel Bruinenberg; Lude Franke; Pim van der Harst; Gerjan Navis; Bruce H R Wolffenbuttel; Ronald P Stolk; Cisca Wijmenga; Dirkje S Postma; Gerard H Koppelman; H Marike Boezen; Judith Vonk; Harold Snieder; Behrooz Z Alizadeh
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

7.  Including selective metabolic components in current diagnostic criteria does not improve discriminative validity for metabolic syndrome: a risk score approach.

Authors:  Huan-Cheng Chang; Sheng-Pyng Chen; Hao-Jan Yang
Journal:  J Int Med Res       Date:  2019-01-24       Impact factor: 1.573

8.  Six-year follow-up study on the association between white blood cell count and fasting blood glucose level in Chinese adults: A community-based health examination survey.

Authors:  Xiu Zang; Xiangyu Meng; Yun Wang; Xiao Jin; Tingting Wu; Xuekui Liu; Houfa Geng; Wei Xu; Yu Wang; Fei Teng; Qinqin Qiu; Manqing Yang; Jun Liang
Journal:  Diabetes Metab Res Rev       Date:  2019-02-06       Impact factor: 4.876

9.  Subnormal peripheral blood leukocyte counts are related to the lowest prevalence and incidence of metabolic syndrome: Tianjin chronic low-grade systemic inflammation and health cohort study.

Authors:  Shaomei Sun; Hongmei Wu; Qing Zhang; Chongjin Wang; Yinting Guo; Huanmin Du; Li Liu; Qiyu Jia; Xing Wang; Kun Song; Kaijun Niu
Journal:  Mediators Inflamm       Date:  2014-04-29       Impact factor: 4.711

10.  Description and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model.

Authors:  Xiaoxiao Chen; Qicai Chen; Lili Chen; Pengpeng Zhang; Juan Xiao; Shumei Wang
Journal:  BMC Public Health       Date:  2014-10-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.